Women’s marathon world record-holder Ruth Chepngetich has been provisionally suspended by the Athletics Integrity Unit (AIU) after testing positive for hydrochlorothiazide (HCTZ), a banned diuretic. The substance was detected in a sample collected from the Kenyan athlete on March 14. The AIU stated that while Chepngetich was initially notified without suspension, she voluntarily opted for a provisional ban on April 19 as investigations continued.
AIU Investigation Leads to Formal Suspension
AIU Head Brett Clothier confirmed that the organization continued its probe before issuing a formal Notice of Charge and imposing its own provisional suspension. HCTZ, a drug used to treat hypertension and fluid retention, is prohibited in sports due to its potential to mask other performance-enhancing substances. The AIU emphasized that diuretics like HCTZ can be abused to conceal doping, raising concerns over fair competition.
Chepngetich’s Record-Breaking Career Under Scrutiny
Chepngetich made history in October 2023 by smashing the women’s marathon world record in Chicago, clocking an unprecedented 2:09:56—the first woman to break the 2:10 barrier. However, her recent withdrawal from the London Marathon in April, citing mental and physical unpreparedness, has now come under renewed scrutiny following the doping allegations. Her agent has yet to comment on the suspension.
Doping Controversy Shocks Athletics World
The provisional suspension has sent shockwaves through the athletics community, casting a shadow over Chepngetich’s achievements. The case highlights ongoing concerns about doping in endurance sports, particularly among Kenyan athletes, who have faced multiple anti-doping violations in recent years. As the investigation unfolds, the sports world awaits further developments to determine the impact on Chepngetich’s career and legacy.